Short answer
Dyne Therapeutics, Inc. (DYN) filed an 8-K current report with the SEC on June 17, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement). Filing text contains only signature certification for Dyne Therapeutics’ June 17, 2026 report.
Dyne Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Filing text contains only signature certification for Dyne Therapeutics’ June 17, 2026 report
- No material agreement terms or investor-impacting transaction details provided
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Dyne Therapeutics, Inc. 8-K filings
Get the next DYN 8-K as it lands
Follow DYN for push alerts, or ask the research agent what this filing means.